2020Antimicrobial Agents and Chemotherapy64 (8) : e00143-20
Filovirus Antiviral Activity of Cationic Amphiphilic Drugs Is Associated with Lipophilicity and Ability To Induce Phospholipidosis
Gunesch A, Zapatero-Belinchón F, Pinkert L, Steinmann E, Manns M, Schneider G, Pietschmann T, Brönstrup M, von Hahn T
2020Plos Pathogens16 (6) : e1008554
The ATGL lipase cooperates with ABHD5 to mobilize lipids for hepatitis C virus assembly
Vieyres G, Reichert I, Carpentier A, Vondran F, Pietschmann T
2020Acs Synthetic Biology9 (7) : 1638-1649
Controlled Functional Zonation of Hepatocytes In Vitro by Engineering of Wnt Signaling
Wahlicht T, Vièyres G, Bruns S, Meumann N, Büning H, Hauser H, Schmitz I, Pietschmann T, Wirth D
2020Journal of Virology94 (14) : e01690-19
Correction for Haid et al., "Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System"
Haid S, Grethe C, Bankwitz D, Grunwald T, Pietschmann T
2020Plos One15 (7) : e0236447
OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease
Tran H, Morikawa K, Anggakusuma, Zibi R, Thi V, Penin F, Heim M, Quadroni M, Pietschmann T, Gouttenoire J, Moradpour D
2024Frontiers in Immunology15 : 1400348
JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature review
Atschekzei F, Traidl S, Carlens J, Schütz K, von Hardenberg S, Elsayed A, Ernst D, Risser L, Thiele T, Graalmann T, Raab J, Baumann U, Witte T, Sogkas G
2020Antiviral Research177 : 104774
Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry
Blockus S, Sake S, Wetzke M, Grethe C, Graalmann T, Pils M, Le Goffic R, Galloux M, Prochnow H, Rox K, Hüttel S, Rupcic Z, Wiegmann B, Dijkman R, Rameix-Welti M, Eléouët J, Duprex W, Thiel V, Hansen G, Brönstrup M, Haid S, Pietschmann T
2023Rmd Open9 (4) : e003507
Rituximab to treat prolidase deficiency due to a novel pathogenic copy number variation in PEPD
Atschekzei F, Fedchenko M, Elsayed A, Dubrowinskaja N, Graalmann T, Ringshausen F, Witte T, Sogkas G
2020Infectious Diseases and Therapy9 (4) : 837-849
Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals
Behrens G, Cossmann A, Stankov M, Schulte B, Streeck H, Förster R, Bosnjak B, Willenzon S, Boeck A, Thu Tran A, Thiele T, Graalmann T, Kayser M, Zychlinsky Scharff A, Dopfer C, Horke A, Pink I, Witte T, Wetzke M, Ernst D, Jablonka A, Happle C
2017Arthritis Research & Therapy19 (1) : 127
Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study
Akmatov M, Röber N, Ahrens W, Flesch-Janys D, Fricke J, Greiser H, Günther K, Kaaks R, Kemmling Y, Krone B, Linseisen J, Meisinger C, Moebus S, Obi N, Guzman C, Conrad K, Pessler F
